Trajan Group (ASX: TRJ) — Company Overview, News & Financial Data
Trajan Group (ASX:TRJ) offers analytical technologies and engineered components, focusing on chromatography and mass spectrometry.
Trajan Group
Trajan Group is a global developer and manufacturer of analytical and life science products, devices, and solutions. Founded in 2011, the company designs, manufactures, and supplies specialized components, automated laboratory workflows, microsampling devices, and pathology consumables. Its technologies support applications in chromatography, mass spectrometry, disease diagnosis, environmental monitoring, and food testing. Trajan serves pharmaceutical companies, academic research institutions, clinical diagnostic laboratories, and analytical instrumentation manufacturers across global markets. The company operates manufacturing, engineering, and sales facilities in Australia, North America, Europe, and Asia.
Snapshot
Operations
Products and/or services of Trajan Group
- Analytical Consumables and Components: Engineering and manufacturing precision chromatography columns, capillary tubing, precision syringes, and fluidic components used in mass spectrometry and separation science for analytical instrumentation, clinical laboratories, and environmental testing facilities globally.
- Automated Workflow Solutions: Developing integrated laboratory robotics and automated sample preparation systems, including specialized liquid handling and chromatographic automation platforms that streamline high-throughput laboratory workflows for life sciences research and pharmaceutical analysis.
- Microsampling Devices and Technologies: Manufacturing specialized medical devices and biological collection tools designed for blood and fluid microsampling, facilitating remote patient sample collection, trial logistics, and decentralized monitoring for clinical and diagnostic applications.
- Pathology Consumables and Instrumentation: Supplying histology consumables, slide printing systems, coverslippers, and specimen processing tools utilized by hospital networks, diagnostic laboratories, and research institutions to analyze tissues and preserve medical samples.
- Precision Fluidic Systems: Designing specialized microfluidic switches, valves, and precision flow channels that enable accurate chemical separation and targeted fluid routing within analytical chemistry and mass spectrometry systems.
- Sample Preparation and Preservation Products: Providing specialized consumables, extraction devices, and preservation kits engineered to maintain sample integrity and traceability from collection through analytical testing in medical and environmental research.
Trajan Group executive team
- Stephen TomisichFounder, CEO, MD & Executive Director
- Simon BillinghamInterim CFO & Interim Joint Company Secretary
- Robert LyonExecutive Director, Head of Corporate Development & General Counsel
- Nigel GilliganChief Operations Officer
- Andrew Arthur GooleyChief Scientific Officer
- Marie KrsticHead of Corporate Communications & Investor Relations
- Mark Andrew Licciardo B BusJoint Company Secretary
- Rebecca Jayne WilsonInvestor Relations Advisor
Latest news about Trajan Group
Recent announcements
What Trajan Group (TRJ) has told the market, newest first.
- Trajan ShareWise Webinar, Introduction and Trading UpdatePrice sensitive
Key financials
Reported results for Trajan Group, in AUD.
- Market cap
- 38.2M
- Revenue (TTM)
- 161.4M
- P/E ratio
- —
- EPS (diluted, TTM)
- 0.0
- Dividend yield
- —
- Profit margin
- -0.4%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 161.4M | 4.2M | -623K | |
| 166.5M | 3.5M | -4.5M | |
| 155M | 3.4M | -25.3M | |
| 162.2M | 10.2M | 1.9M |